Close Menu
Home » CareDx Receives CE Mark for AlloSeq cfDNA Kit

CareDx Receives CE Mark for AlloSeq cfDNA Kit

Jan 10, 2020
|
staff reporter

NEW YORK – CareDx said on Friday that it has received the CE mark for its AlloSeq cfDNA kit, making it available to transplant patients and clinicians in Europe.

AlloSeq cfDNA is a kit-based product that is used to quantify the level of donor-derived cell-free DNA in transplant recipients in order to measure graft health, and is run on next generation sequencing platforms. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Letter Condemns Virus Conspiracy Theories

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

Philip Leder Dies

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

New and Maybe Important

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

Nucleic Acids Research Studies on Alu Genotyping, Stress Response Histones, Undocumented Small RNAs

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. Novacyt Gets CE Mark for Coronavirus Test

  2. Lucid Diagnostics EsoGuard DNA Test Gets FDA Breakthrough Device Status

  3. Genetron Health Obtains Regulatory Approval in China for NGS Instrument, Lung Cancer Panel

  4. Yourgene Health Gets Australian Approval for Chemotoxicity Assay

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.